Pancreatic Cancer Research

ResearcherMedical College of WisconsinActive in the last 2 years

Charles H. C. Pilgrim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2193-7305; OpenAlex author ID A5040136766. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
41
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 5 papers · 2023: 2 papers · 2024: none · 2025: 4 papers

Papers 16

  1. Do routine narrative style CT reports provide sufficient information to adequately stage pancreatic cancer. Last author DOI 10.1016/j.hpb.2025.05.001↗
  2. Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery. Co-author DOI 10.1016/j.pan.2025.09.029↗
  3. Barriers and hurdles delaying governance approval for an ethically approved nationwide clinical trial in pancreatic cancer. Last author DOI 10.1111/ans.19296↗
  4. Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control and optional supplemental jejunal … Co-author DOI 10.1186/s12937-025-01113-9↗
  5. Characteristics of patients diagnosed with pancreatic cancer who access palliative care: An observational study. Co-author DOI 10.1007/s11136-023-03425-x↗
  6. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. Co-author DOI 10.1016/j.hpb.2023.07.883↗
  7. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer. Co-author DOI 10.1016/j.hpb.2021.11.005↗
  8. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2022.01.011↗
  9. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot. Co-author DOI 10.1111/ans.17999↗
  10. Landscape of clinical trials across the pancreatic cancer care continuum: an Australian perspective. Co-author DOI 10.5694/mja2.51756↗
  11. Systematic review of the predictors of health service use in pancreatic cancer. Co-author PMID 35261792↗
  12. The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial. Co-author DOI 10.4103/eus-d-20-00230↗
  13. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2019.09.002↗
  14. Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. Co-author DOI 10.1371/journal.pone.0243312↗
  15. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. Co-author DOI 10.1016/j.hpb.2018.08.016↗
  16. Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric vein. Co-author DOI 10.1007/s11605-013-2428-6↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Raymond Zalcberg · 14 shared papers, 2019–2025 · strength 2.24
  2. Liane Ioannou · 10 shared papers, 2019–2025 · strength 1.45
  3. Sue Evans · 9 shared papers, 2019–2025 · strength 1.22
  4. Daniel Gerald Croagh · 8 shared papers, 2019–2025 · strength 0.99
  5. Rachel Ε. Neale · 6 shared papers, 2019–2025 · strength 0.70
  6. Ashika D. Maharaj · 6 shared papers, 2019–2025 · strength 0.70
  7. Neil Donald Merrett · 6 shared papers, 2019–2025 · strength 0.70
  8. Kate White · 6 shared papers, 2019–2025 · strength 0.70
  9. James G. Kench · 5 shared papers, 2019–2025 · strength 0.61
  10. Jennifer A. M. Philip · 5 shared papers, 2019–2023 · strength 0.55
  11. Nadia N. Khan · 3 shared papers, 2022–2023 · strength 0.51
  12. David Goldstein · 3 shared papers, 2022–2025 · strength 0.45
  13. Luc te Marvelde · 2 shared papers, 2022–2023 · strength 0.35
  14. Hasna Kazi · 1 shared paper, 2025 · strength 0.33
  15. Trevor Leong · 3 shared papers, 2020–2022 · strength 0.29
  16. Joanne Lundy · 2 shared papers, 2021–2025 · strength 0.28
  17. Jaswinder Singh Samra · 2 shared papers, 2019–2025 · strength 0.27
  18. Koroush Shahsavar Haghighi · 2 shared papers, 2019–2025 · strength 0.27
  19. David Goldstein · 3 shared papers, 2019–2020 · strength 0.25
  20. Elizabeth A. Burmeister · 2 shared papers, 2022 · strength 0.24
  21. Ariadna Recasens · 1 shared paper, 2025 · strength 0.24
  22. Kate Furness · 1 shared paper, 2025 · strength 0.19
  23. Lauren Hanna · 1 shared paper, 2025 · strength 0.19
  24. Mahesh Iddawela · 1 shared paper, 2025 · strength 0.19
  25. Emma McShane · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.